$3250 | Single User
$4650 | Site License
$5650 | Global License

Inflammatory Bowel Disease (IBD) Treatment Market, By Type (Crohn’s Disease, and Ulcerative Colitis), By Route of Administration (Oral, and Injectable), By Distribution Channel (Online Pharmacy, Retail Pharmacy, and Hospital Pharmacy), and By Geography (NA, EU, APAC, LATAM and MEA) – Analysis, Share, Trends, Size, & Forecast from 2020 – 2026- COVID-19 Updated
[Lowest Price Guaranteed: $3,250]

Published by AnalystView: 01 Jun 2020 | 270623 | In Stock
Related Topics: Agencies , Healthcare , Inflammatory Bowel Disease (IBD) , Medical , Pfizer , Pharmaceuticals , Pharmacy , Retail , Services , Ulcerative Colitis

Introduction

REPORT HIGHLIGHT

Inflammatory Bowel Disease (IBD) Treatment market was valued at USD 15.87 billion by 2019, growing with 4.1% CAGR during the forecast period, 2020-2026

Market Dynamics

A rise in the number of drugs available in clinical tests, growing prevalence of inflammatory bowel disease (IBD), and rising government initiatives related to the analysis of the causes and effective novel drug developments are the major factors driving the growth of global IBD treatment market. In addition, the high prevalence of and growing occurrence of ulcerative colitis and Chron's disease are likely to create growth opportunities in the IBD treatment market in the projected timeframe. However, stringent drug regulatory policies and lack of treatment effectiveness are predicted to impede the market growth in the coming future.

Types Takeaway

The Crohn’s disease type segment accounted for the majority of share in 2019 and is expected to rise at an impressive growth rate during the forecast period. This growth is primarily owing to the growing prevalence of the condition. As per a published article in 2018 in Jobson Medical Information LLC, the occurrence of Chron’s disease was found to be approximately 3.1 to 14.6 cases per 100,000 people each year and the incidence in the U.S. was around 201 cases per 100,000 adults. On the other hand, the ulcerative colitis segment is expected to grow at the fastest rate throughout the forecast majorly due to presence of strong pipeline for the treatment of ulcerative colitis.

Route of Distribution Takeaway

The injectables route of administration segment is considered to be the largest due to its efficacy. Additionally, the development of biosimilars such as Inflectra is likely to boost the segmental market growth. Along with injectables, the oral route segment is projected to be the fastest-growing market by 2030 owing to the presence of strong pipeline products. The ASAs sub-segment of the oral route of administration subjugated the market in 2019 and the AK inhibitors sub-segment is estimated to grow at the fastest pace during the period of forecast.

Distribution Channel Takeaway

By distribution channel, the hospital pharmacy segment including both out-patient and in-patient subjugated the market in 2018 and is predicted to grow exponentially throughout the forecast. This is majorly owing to the rising prevalence of ulcerative colitis and Crohn’s disease coupled with a growing total number of hospitalizations all across the globe. On the other hand, the online pharmacy is predicted to be the fastest-growing segmental market by the end of 2030. The increasing demand and rising trend of online purchasing are contributing to the growth of online pharmacy segment. In addition, customers find online pharmacy beneficial due to the availability of various offers and discounts.

Regional Takeaway

Presently, the North America market for IBD treatment is playing a dominant role owing to the presence of major market players and sophisticated healthcare infrastructure. The region is expected to lead the market during the period of forecast due to rising prevalence of Chron’s diseases & ulcerative colitis and the growing increasing geriatric population in the U.S. On the other hand, the Asia Pacific region is estimated to grow at the fastest pace by the end of 2030 due to increasing product approvals in this region.

Key players of the market include:

• Pfizer Inc.

• AbbVie Inc.

• Cosmo Pharmaceuticals

• UCB S.A.

• Innovate Biopharmaceuticals

• Gilead Sciences

• Celgene Corporation

• Celltrion Healthcare Co., Ltd.

• Johnson & Johnson Services Inc.

• Takeda Pharmaceutical Company Limited

The market size and forecast for each segment and sub-segments has been considered as below:

• Historical Year – 2015 to 2018

• Base Year – 2019

• Estimated Year – 2020

• Projected Year – 2026

TARGET AUDIENCE

 Traders, Distributors, and Suppliers

 Manufacturers

 Government and Regional Agencies

 Research Organizations

 Consultants

 Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION

 Oral

o 5-Aminosalicylic Acid

o Corticosteroids

o Janus Kinase (JAK) Inhibitors

o Others

 Injectable

o Tumor Necrosis Factor (TNF) Inhibitors

o Interleukin inhibitors

o Anti-integrin

o Others

GLOBAL INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET, BY TYPE

 Chron’s Disease

 Ulcerative Colitis

 Others

GLOBAL INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET, BY DISTRIBUTION CHANNEL

 Retail Pharmacy

 Hospital Pharmacy

 Online Pharmacy

 Others

GLOBAL INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET, BY REGION

 North America

o The U.S.

o Canada

 Europe

o Germany

o France

o Italy

o Spain

o United Kingdom

o Rest of Europe

 Asia Pacific

o India

o China

o South Korea

o Japan

o Singapore

o Rest of APAC

 Latin America

o Brazil

o Mexico

o Argentina

o Rest of LATAM

 Middle East and Africa

o Saudi Arabia

o United Arab Emirates

o Rest of MEA

Table of Contents
for Inflammatory Bowel Disease (IBD) Treatment Market, By Type (Crohn’s Disease, and Ulcerative Colitis), By Route of Administration (Oral, and Injectable), By Distribution Channel (Online Pharmacy, Retail Pharmacy, and Hospital Pharmacy), and By Geography (NA, EU, APAC, LATAM and MEA) – Analysis, Share, Trends, Size, & Forecast from 2020 – 2026- COVID-19 Updated

  • TABLE OF CONTENT

    1. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET OVERVIEW

    1.1. Study Scope

    1.2. Assumption and Methodology

    2. EXECUTIVE SUMMARY

    2.1. Market Snippet

    2.1.1. Market Snippet by Route of Administration

    2.1.2. Market Snippet by Type

    2.1.3. Market Snippet by Distribution Channel

    2.1.4. Market Snippet by Region

    2.2. Competitive Insights

    3. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT KEY MARKET TRENDS

    3.1. Market Drivers

    3.1.1. Impact Analysis of Market Drivers

    3.2. Market Restraints

    3.2.1. Impact Analysis of Market Restraints

    3.3. Market Opportunities

    3.4. Market Future Trends

    4. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT INDUSTRY STUDY

    4.1. Porter’s Five Forces Analysis

    4.2. Marketing Strategy Analysis

    4.3. Growth Prospect Mapping

    4.4. Regulatory Framework Analysis

    4.5. COVID-19 Impact Analysis

    4.5.1. Pre-COVID-19 Impact Analysis

    4.5.2. Post-COVID-19 Impact Analysis

    5. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET LANDSCAPE

    5.1. Market Share Analysis

    5.2. Key Innovators

    5.3. Breakdown Data, by Key manufacturer

    5.3.1. Established Player Analysis

    5.3.2. Emerging Player Analysis

    6. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET – BY ROUTE OF ADMINISTRATION

    6.1. Overview

    6.1.1. Segment Share Analysis, By Route of Administration, 2019 & 2026 (%)

    6.2. Oral

    6.2.1. Overview

    6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    6.2.3. 5-Aminosalicylic Acid

    6.2.3.1. Overview

    6.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    6.2.4. Corticosteroids

    6.2.4.1. Overview

    6.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    6.2.5. Janus Kinase (JAK) Inhibitors

    6.2.5.1. Overview

    6.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    6.2.6. Others

    6.2.6.1. Overview

    6.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    6.3. Injectable

    6.3.1. Overview

    6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    6.3.3. Tumor Necrosis Factor (TNF) Inhibitors

    6.3.3.1. Overview

    6.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    6.3.4. Interleukin inhibitors

    6.3.4.1. Overview

    6.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    6.3.5. Anti-integrin

    6.3.5.1. Overview

    6.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    6.3.6. Others

    6.3.6.1. Overview

    6.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    7. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET – BY TYPE

    7.1. Overview

    7.1.1. Segment Share Analysis, By Type, 2019 & 2026 (%)

    7.2. Chron's Disease

    7.2.1. Overview

    7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    7.3. Ulcerative Colitis

    7.3.1. Overview

    7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    7.4. Others

    7.4.1. Overview

    7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET – BY DISTRIBUTION CHANNEL

    8.1. Overview

    8.1.1. Segment Share Analysis, By Distribution Channel, 2019 & 2026 (%)

    8.2. Retail Pharmacy

    8.2.1. Overview

    8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.3. Hospital Pharmacy

    8.3.1. Overview

    8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.4. Online Pharmacy

    8.4.1. Overview

    8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    9. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET– BY GEOGRAPHY

    9.1. Introduction

    9.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)

    9.2. North America

    9.2.1. Overview

    9.2.2. Key Manufacturers in North America

    9.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)

    9.2.4. North America Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)

    9.2.5. North America Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)

    9.2.6. North America Market Size and Forecast, By Route of Administration, 2015 - 2026 (US$ Million)

    9.2.7. U.S.

    9.2.7.1. Overview

    9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    9.2.8. Canada

    9.2.8.1. Overview

    9.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    9.3. Europe

    9.3.1. Overview

    9.3.2. Key Manufacturers in Europe

    9.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)

    9.3.4. Europe Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)

    9.3.5. Europe Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)

    9.3.6. Europe Market Size and Forecast, By Route of Administration, 2015 - 2026 (US$ Million)

    9.3.7. Germany

    9.3.7.1. Overview

    9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    9.3.8. Italy

    9.3.8.1. Overview

    9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    9.3.9. United Kingdom

    9.3.9.1. Overview

    9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    9.3.10. France

    9.3.10.1. Overview

    9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    9.3.11. Rest of Europe

    9.3.11.1. Overview

    9.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    9.4. Asia Pacific (APAC)

    9.4.1. Overview

    9.4.2. Key Manufacturers in Asia Pacific

    9.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)

    9.4.4. Asia Pacific Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)

    9.4.5. Asia Pacific Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)

    9.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2015 - 2026 (US$ Million)

    9.4.7. India

    9.4.7.1. Overview

    9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    9.4.8. China

    9.4.8.1. Overview

    9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    9.4.9. Japan

    9.4.9.1. Overview

    9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    9.4.10. South Korea

    9.4.10.1. Overview

    9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    9.4.11. Rest of APAC

    9.4.11.1. Overview

    9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    9.5. Latin America

    9.5.1. Overview

    9.5.2. Key Manufacturers in Latin America

    9.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)

    9.5.4. Latin America Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)

    9.5.5. Latin America Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)

    9.5.6. Latin America Market Size and Forecast, By Route of Administration, 2015 - 2026 (US$ Million)

    9.5.7. Brazil

    9.5.7.1. Overview

    9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    9.5.8. Mexico

    9.5.8.1. Overview

    9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    9.5.9. Argentina

    9.5.9.1. Overview

    9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    9.5.10. Rest of LATAM

    9.5.10.1. Overview

    9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    9.6. Middle East and Africa

    9.6.1. Overview

    9.6.2. Key Manufacturers in Middle East and Africa

    9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)

    9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)

    9.6.5. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)

    9.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2015 - 2026 (US$ Million)

    9.6.7. Saudi Arabia

    9.6.7.1. Overview

    9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    9.6.8. United Arab Emirates

    9.6.8.1. Overview

    9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    10. KEY VENDOR ANALYSIS

    10.1. Pfizer Inc.

    10.1.1. Company Snapshot

    10.1.2. Financial Performance

    10.1.3. Product Benchmarking

    10.1.4. Strategic Initiatives

    10.2. AbbVie Inc.

    10.3. Cosmo Pharmaceuticals

    10.4. UCB S.A.

    10.5. Innovate Biopharmaceuticals

    10.6. Gilead Sciences

    10.7. Celgene Corporation

    10.8. Celltrion Healthcare Co., Ltd.

    10.9. Johnson & Johnson Services Inc.

    10.10. Takeda Pharmaceutical Company Limited

    11. 360 DEGREE ANALYSTVIEW

    12. APPENDIX

    12.1. Research Methodology

    12.2. References

    12.3. Abbreviations

    12.4. Disclaimer

    12.5. Contact Us

List Of Tables
in Inflammatory Bowel Disease (IBD) Treatment Market, By Type (Crohn’s Disease, and Ulcerative Colitis), By Route of Administration (Oral, and Injectable), By Distribution Channel (Online Pharmacy, Retail Pharmacy, and Hospital Pharmacy), and By Geography (NA, EU, APAC, LATAM and MEA) – Analysis, Share, Trends, Size, & Forecast from 2020 – 2026- COVID-19 Updated

List of Tables

TABLE List of data sources

TABLE Market drivers; Impact Analysis

TABLE Market restraints; Impact Analysis

TABLE Inflammatory Bowel Disease (IBD) Treatment market: Route of Administration Snapshot (2018)

TABLE Segment Dashboard; Definition and Scope, by Route of Administration

TABLE Global Inflammatory Bowel Disease (IBD) Treatment market, by Route of Administration 2015-2026 (USD Million)

TABLE Inflammatory Bowel Disease (IBD) Treatment market: Type Snapshot (2018)

TABLE Segment Dashboard; Definition and Scope, by Type

TABLE Global Inflammatory Bowel Disease (IBD) Treatment market, by Type 2015-2026 (USD Million)

TABLE Inflammatory Bowel Disease (IBD) Treatment market: Distribution Channel Snapshot (2018)

TABLE Segment Dashboard; Definition and Scope, by Distribution Channel

TABLE Global Inflammatory Bowel Disease (IBD) Treatment market, by Distribution Channel 2015-2026 (USD Million)

TABLE Inflammatory Bowel Disease (IBD) Treatment market: Regional snapshot (2018)

TABLE Segment Dashboard; Definition and Scope, by Region

TABLE Global Inflammatory Bowel Disease (IBD) Treatment market, by Region 2015-2026 (USD Million)

TABLE North America Inflammatory Bowel Disease (IBD) Treatment market, by Country, 2015-2026 (USD Million)

TABLE North America Inflammatory Bowel Disease (IBD) Treatment market, by Type, 2015-2026 (USD Million)

TABLE North America Inflammatory Bowel Disease (IBD) Treatment market, by Distribution Channel, 2015-2026 (USD Million)

TABLE North America Inflammatory Bowel Disease (IBD) Treatment market, by Route of Administration, 2015-2026 (USD Million)

TABLE Europe Inflammatory Bowel Disease (IBD) Treatment market, by country, 2015-2026 (USD Million)

TABLE Europe Inflammatory Bowel Disease (IBD) Treatment market, by Type, 2015-2026 (USD Million)

TABLE Europe Inflammatory Bowel Disease (IBD) Treatment market, by Distribution Channel, 2015-2026 (USD Million)

TABLE Europe Inflammatory Bowel Disease (IBD) Treatment market, by Route of Administration, 2015-2026 (USD Million)

TABLE Asia Pacific Inflammatory Bowel Disease (IBD) Treatment market, by country, 2015-2026 (USD Million)

TABLE Asia Pacific Inflammatory Bowel Disease (IBD) Treatment market, by Type, 2015-2026 (USD Million)

TABLE Asia Pacific Inflammatory Bowel Disease (IBD) Treatment market, by Distribution Channel, 2015-2026 (USD Million)

TABLE Asia Pacific Inflammatory Bowel Disease (IBD) Treatment market, by Route of Administration, 2015-2026 (USD Million)

TABLE Latin America Inflammatory Bowel Disease (IBD) Treatment market, by country, 2015-2026 (USD Million)

TABLE Latin America Inflammatory Bowel Disease (IBD) Treatment market, by Route of Administration, 2015-2026 (USD Million)

TABLE Latin America Inflammatory Bowel Disease (IBD) Treatment market, by Type, 2015-2026 (USD Million)

TABLE Latin America Inflammatory Bowel Disease (IBD) Treatment market, by Distribution Channel, 2015-2026 (USD Million)

TABLE Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment market, by country, 2015-2026 (USD Million)

TABLE Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment market, by Type, 2015-2026 (USD Million)

TABLE Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment market, by Distribution Channel, 2015-2026 (USD Million)

TABLE Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment market, by Route of Administration, 2015-2026 (USD Million)

List Of Figures, Charts and Diagrams
in Inflammatory Bowel Disease (IBD) Treatment Market, By Type (Crohn’s Disease, and Ulcerative Colitis), By Route of Administration (Oral, and Injectable), By Distribution Channel (Online Pharmacy, Retail Pharmacy, and Hospital Pharmacy), and By Geography (NA, EU, APAC, LATAM and MEA) – Analysis, Share, Trends, Size, & Forecast from 2020 – 2026- COVID-19 Updated

List of Figures

FIGURE Inflammatory Bowel Disease (IBD) Treatment market segmentation

FIGURE Market research methodology

FIGURE Value chain analysis

FIGURE Porter’s Five Forces Analysis

FIGURE Market Attractiveness Analysis

FIGURE COVID-19 Impact Analysis

FIGURE Pre & Post COVID-19 Impact Comparision Study

FIGURE Competitive Landscape; Key company market share analysis, 2018

FIGURE Route of Administration segment market share analysis, 2019 & 2026

FIGURE Route of Administration segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Oral segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE 5-Aminosalicylic Acid segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Corticosteroids segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Janus Kinase (JAK) Inhibitors segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Injectable segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Tumor Necrosis Factor (TNF) Inhibitors segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Interleukin inhibitors segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Anti-integrin segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Type segment market share analysis, 2019 & 2026

FIGURE Type segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Chron’s Disease segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Ulcerative Colitis segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Distribution Channel segment market share analysis, 2019 & 2026

FIGURE Distribution Channel segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Retail Pharmacy segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Hospital Pharmacy segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Online Pharmacy market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Regional segment market share analysis, 2019 & 2026

FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE North America Inflammatory Bowel Disease (IBD) Treatment market share and leading players, 2018

FIGURE Europe Inflammatory Bowel Disease (IBD) Treatment market share and leading players, 2018

FIGURE Asia Pacific Inflammatory Bowel Disease (IBD) Treatment market share and leading players, 2018

FIGURE Latin America Inflammatory Bowel Disease (IBD) Treatment market share and leading players, 2018

FIGURE Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment market share and leading players, 2018

FIGURE North America Inflammatory Bowel Disease (IBD) Treatment market share analysis by country, 2018

FIGURE U.S. Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Canada Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Europe Inflammatory Bowel Disease (IBD) Treatment market share analysis by country, 2018

FIGURE Germany Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Spain Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Italy Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE UK Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE France Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Rest of the Europe Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Asia Pacific Inflammatory Bowel Disease (IBD) Treatment market share analysis by country, 2018

FIGURE India Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE China Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Japan Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE South Korea Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Singapore Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Rest of APAC Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Latin America Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Latin America Inflammatory Bowel Disease (IBD) Treatment market share analysis by country, 2018

FIGURE Brazil Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Mexico Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Argentina Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Rest of LATAM Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment market share analysis by country, 2018

FIGURE Saudi Arabia Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE United Arab Emirates Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

Additional Details

Publisher

AnalystView

Publisher Information

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.



These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.



We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.



We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.



It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Reference

270623 | AV79

Number of Pages

154

Report Format

PDF

AnalystView Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments
Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval o...
01 Dec 2016 by GBI Research USD $4,995 More Info
Inflammatory Pain Global Clinical Trials Review, H2, 2016
Inflammatory Pain Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, ...
30 Nov 2016 by Global Data USD $2,500 More Info
Global Inflammatory Bowel Disease Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Nov 2016 by Current Partnering USD $1,495 More Info
Global Inflammatory Bowel Disease Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Competitor Analysis: Bispecific Antibodies for Cancer, Inflammatory & Other Diseases
Competitor Analysis: Bispecific Antibodies for Cancer, Inflammatory & Other DiseasesThis Compet...
01 Jun 2016 by La Merie USD $560 More Info
Competitor Analysis: Bispecific Antibodies for Cancer, Inflammatory & Other Diseases
Competitor Analysis: Bispecific Antibodies for Cancer, Inflammatory & Other DiseasesThis Compet...
01 Jun 2016 by La Merie USD $560 More Info
Inflammatory Pain Global Clinical Trials Review, H1, 2016
Inflammatory Pain Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, ...
16 Mar 2016 by Global Data USD $2,500 More Info
Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015
Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015SummaryGlobal...
30 Dec 2015 by Global Data USD $2,500 More Info
Inflammatory Skin Diseases Global Clinical Trials Review, H2, 2015
Inflammatory Skin Diseases Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial...
30 Nov 2015 by Global Data USD $2,500 More Info
Medical Affairs Reputation (EU5): Biosimilar mAbs in Inflammatory Disorders
IntroductionBased on survey results from 150 rheumatologists, dermatologists, and gastroenterologist...
01 Feb 2015 by FirstWord Pharma USD $5,995 More Info

This report is published by AnalystView

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.

These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.

We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.

We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.

It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Download Free Report Summary PDF

Inflammatory Bowel Disease (IBD) Treatment Market, By Type (Crohn’s Disease, and Ulcerative Colitis), By Route of Administration (Oral, and Injectable), By Distribution Channel (Online Pharmacy, Retail Pharmacy, and Hospital Pharmacy), and By Geography (NA, EU, APAC, LATAM and MEA) – Analysis, Share, Trends, Size, & Forecast from 2020 – 2026- COVID-19 Updated | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...